Profile: Access Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on adding value to exciting product concepts in research by advancing those products through clinical development. Our ProLindac is an oncology drug that utilizes a safe, water-soluble nanoparticulate system to deliver DACH platinum to tumors. Our Mugard is a viscous, mucoadhesive rinse which provides a protective coating to the oral mucosa. Our Econazole is a topical anti-fungal agent that effectively inhibits in vitro growth of the fungi most commonly implicated in onychomycosis.